Disease

Alzheimer Dementia

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 20, 2026 · PHASE 2 TRIAL

Fisetin in Mild Alzheimer's Disease

ClinicalTrials.gov

This is a completed Phase 2 pilot study with very small enrollment (n=5) assessing only safety and tolerability of fisetin; no efficacy results are reported in this registry record.

PreliminaryAlzheimer Dementia (AD)Fisetin Alzheimer Dementia

Reported

Enrollment5

PhasePhase 2

Primary outcome measureIncidence of Treatment-Emergent Adverse Eve…

AUG 17, 2026 · PHASE 2/3 TRIAL

Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

ClinicalTrials.gov

This is a clinical trial registry record with no reported results; the study is actively recruiting and in Phase 2/3, so only design and planned endpoints are documented.

PreliminaryAlzheimer Dementia Wanbangde Pharmaceutical Group Co.Huperzine A Controlled-Release Tablets

Reported

Planned enrollment720

PhasePhase 2, Phase 3

Primary outcome measure 1ADAS-Cog11 at week 24